title: Hemodynamic and tubular effects of endothelin and thromboxane in the isolated perfused rat kidney.
abstract: We have investigated the effects of the endothelium-derived peptide, endothelin, and of a chemically stable analog of thromboxane (TX) A2, U46619, on the glomerular hemodynamics and tubular function of isolated, perfused rat kidneys. Endothelin (10(-11)-10(-9) M) dose dependently decreased the renal plasma flow to a significantly greater extent than it did the glomerular filtration rate. In contrast, U46619 (10(-9)-10(-7) M) had more pronounced effects on the glomerular filtration rate than on the renal plasma flow. As a consequence, the filtration fraction was increased by endothelin and decreased by U46619. Endothelin, unlike U46619, enhanced urinary Na+ excretion and reduced oxygen consumption at concentrations that greatly decreased the tubular load, thus suggesting that it has a direct effect on tubular Na+ reabsorption. Addition of the TXA2/PGH2-receptor antagonist, BM13177 (4.10(-4) M), or the cyclooxygenase inhibitor, acetylsalicylic acid (10(-3) M), to the perfusion medium failed to modify the endothelin-induced increase in Na+ excretion or the reduction in renal plasma flow, whereas acetylsalicylic acid, but not BM13177, partially prevented the decrease in the glomerular filtration rate. These results demonstrate that two contractile agonists produced by the kidney have specific and differential effects on cortical and tubular functions. Moreover, the intrarenal production of eicosanoids does not appear to play a major role in the renal effects of endothelin.
authors.affiliation: Cardiovascular Department, Farmitalia Carlo Erba-Erbamont Group Research Laboratories, Milano, Italy.
authors.forename: R G
authors.initials: RG
authors.lastname: Ferrario
authors.forename: R
authors.initials: R
authors.lastname: Foulkes
authors.forename: P
authors.initials: P
authors.lastname: Salvati
authors.forename: C
authors.initials: C
authors.lastname: Patrono
mesh_terms: D019796:15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; D000818:Animals; D015777:Eicosanoids / Q000502:physiology; D016232:Endothelins; D066298:In Vitro Techniques; D007684:Kidney Tubules / Q000187:drug effects*; D008297:Male; D010455:Peptides / Q000494:pharmacology*; D010477:Perfusion; D011450:Prostaglandin Endoperoxides, Synthetic / Q000494:pharmacology; D051381:Rats; D012079:Renal Circulation / Q000187:drug effects*; D013931:Thromboxanes / Q000008:administration & dosage / Q000494:pharmacology*
chemical_list: D015777:Eicosanoids; D016232:Endothelins; D010455:Peptides; D011450:Prostaglandin Endoperoxides, Synthetic; D013931:Thromboxanes; D019796:15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid